Article
Enzyme inhibitors may help in cancer therapy following initial procedures
Certain enzyme inhibitors may slow tumor formation within weeks and could lead to treatments that retard or prevent recurrences of cancers, researchers at UT Southwestern Medical Center at Dallas have discovered.
Related Videos
John Michael DiBianco, MD, on silicone vs polyurethane stents for patients with kidney stones
Félix Guerrero-Ramos, MD, on TAR-200 in papillary disease-only NMIBC
BPH Treatment and Impact on Sexual Health
Khurshid Ghani, MD, on trial of stent omission following ureteroscopy
Karyn S. Eilber, MD, shares her reaction to genitourinary syndrome of menopause guidelines
Expert discusses the relationship between RCTs and real-world efficacy of prostate cancer treatments
Treatment Decisions in Patients With Low- vs High-Volume Disease
Findings in the Docetaxel-Naive Patient Population
Endourologist discusses shared decision-making and laser lithotripsy
Shreyas Joshi, MD, recaps AUA session on chemotherapy vs novel NMIBC options
Related Content
